Stock listing
PLX Stock Price, News, Filings & Events — Protalix Biotherapeutics, Inc. (de)
Selected listing: PLX · AMEX · USD · US
This page tracks Protalix Biotherapeutics, Inc. (de)'s PLX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLX:AMEX. PLX:AMEX is the stock-level entry point for investors researching Protalix Biotherapeutics, Inc. (de), while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Protalix Biotherapeutics, Inc. is a public company traded under the ticker PLX in the American market. The company has a market capitalization of approximately $191.76 million. Protalix focuses on developing biopharmaceuticals using its proprietary plant cell-based protein expression system.
- Ticker
- PLX:AMEX
- Asset type
- Stock
- Market cap
- $204.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- AMEX
- Currency
- USD
Protalix Biotherapeutics, Inc. (de) PLX:AMEX stock context
This page tracks Protalix Biotherapeutics, Inc. (de)'s PLX:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PLX:AMEX. PLX:AMEX is the stock-level entry point for investors researching Protalix Biotherapeutics, Inc. (de), while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Protalix Biotherapeutics, Inc. is a public company traded under the ticker PLX in the American market. The company has a market capitalization of approximately $191.76 million. Protalix focuses on developing biopharmaceuticals using its proprietary plant cell-based protein expression system.
Latest news from Protalix Biotherapeutics, Inc. (de)
Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results
August 12, 2026
Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results
May 13, 2026
Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026
May 6, 2026
Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results
March 18, 2026
Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026
March 11, 2026
Protalix Biotherapeutics, Inc. (de) earnings calls
Protalix BioTherapeutics, Inc. (DE) (PLX) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Protalix BioTherapeutics, Inc. (DE) (PLX) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Protalix BioTherapeutics, Inc. (DE) (PLX) Q4 2025 Earnings Call
March 18, 2026 · Replay with transcript and chapters
Protalix BioTherapeutics, Inc. (DE) (PLX) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Protalix BioTherapeutics, Inc. (DE) (PLX) Q2 2025 Earnings Call
August 14, 2025 · Replay with transcript and chapters
Protalix BioTherapeutics, Inc. (DE) (PLX) Q1 2025 Earnings Call
May 9, 2025 · Replay with transcript and chapters
Research Protalix Biotherapeutics, Inc. (de)
Protalix Biotherapeutics, Inc. (de) investor report
Review AI stock analysis and investor report context for PLX:AMEX.
Protalix Biotherapeutics, Inc. (de) company profile
View the public company page for Protalix Biotherapeutics, Inc. (de) on 6ix.
Protalix Biotherapeutics, Inc. (de) news
Read company news and market updates connected to Protalix Biotherapeutics, Inc. (de).
Protalix Biotherapeutics, Inc. (de) investor events
Find investor webinars, events, and replay context for Protalix Biotherapeutics, Inc. (de).
Alternate listings
PBDA:GETTEX
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
PLX:BOATS
US · USD
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
A2PWSL:LSX
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
A2PWSL:LS
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
PBDA:FWB
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
PBDA:SWB
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
PBDA:DUS
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
PBDA:MUN
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.
PBDA:TRADEGATE
DE · EUR
Alternate listing for Protalix Biotherapeutics, Inc. (de); the primary context on this page is PLX:AMEX.